Background: Dystrophin is the product of the gene that is mutated in Duchenne muscular dystrophy (DMD), a progressive neuromuscular disease for which no treatment is available. Mice carrying a mutation in the gene for dystrophin (mdx mice) display only a mild phenotype, but it is aggravated when combined with a mutation in the MyoD gene. The nematode worm Caenorhabditis elegans has a dystrophin homologue (dys-1), but null mutations in dys-1 do not result in muscle degeneration.
Background
Dystrophin is the product of the gene that is mutated in Duchenne and Becker muscular dystrophies (DMD and BMD), two progressive neuromuscular diseases affecting approximately 1 in 3,500 male births [1] . Dystrophin is a 3,685 amino acid protein found in skeletal and cardiac muscles [2] . Shorter forms of the protein are generated by internal promoters [3] . Dystrophin is located under the sarcolemma, bound by its amino-terminal end to actin filaments, and by its carboxy-terminal end to a transmembrane complex of glycoproteins (DGC) [3] . As α-dystroglycan, an extracellular component of the DGC, binds the extracellular matrix (ECM), it is considered that dystrophin and the DGC form a link between the ECM and the cytoskeleton [3] [4] [5] . Despite extensive biochemical and cellular characterisation, the function of this link is still poorly understood. Moreover, the mechanism of the muscle degeneration observed in DMD patients is not yet known.
In mammals, utrophin, a ubiquitously expressed protein very similar to dystrophin, is partly redundant with dystrophin [6] . A third dystrophin-like protein, DRP2, is expressed only in the nervous system [7] . Mice carrying a mutation in the dystrophin gene (mdx mice) display only a mild myopathy [8] , indicating that humans and mice do not compensate similarly for the absence of dystrophin.
Mice carrying mutations in both the dystrophin and utrophin genes have severe myopathies [9, 10] , but the relevance of this model to DMD is uncertain. The canine model of DMD, known as golden retriever muscular dystrophy (GRMD), is much closer to the human pathology [11] , but for ethical reasons cannot be used extensively in research.
Invertebrates possess only one dystrophin-like gene [12] . The presence of a dystrophin homologue in the genome of genetically tractable animals such as the nematode worm Caenorhabditis elegans or the fruit fly Drosophila offers an opportunity to tackle the question of dystrophin function by forward genetics, an approach which has proven promising for other human pathologies [13, 14] . The advantage of this approach is the ability to address a biological question without any prior knowledge of the genes and proteins involved. We have undertaken an analysis of dystrophin function in C. elegans. Worms carrying putative null mutations of the dystrophin-like gene dys-1 display a specific but subtle behavioral defect consisting of hyperactive locomotion, exaggerated bending of the head, and a tendency to hypercontract [15] . They show no sign of muscle degeneration [15] . The lack of muscle degeneration in dys-1 animals can be explained by the short lifespan of the animals, as the phenotypes take weeks to appear in mammals [15] .
In this paper, we report that placing the dys-1 mutation in a weak hlh-1 genetic background leads to a time-dependent muscle degeneration. We also report the cloning of dyc-1, a novel gene for which loss-of-function mutations resemble that of dys-1. Overexpression of dyc-1 resulted in partial suppression of the degeneration phenotype of dys-1; hlh-1 animals.
Results
Progressive myopathy in dys-1(cx18); hlh-1(cc561ts) double mutants As mice lacking both dystrophin and the myogenic factor MyoD display severe myopathy, compared with mdx mice [16] , we tested the effect of combining the analogous mutations in C. elegans. The C. elegans homologue of the MyoD gene is the hlh-1 gene, of which null alleles are lethal [17, 18] . In this study, we used the thermosensitive allele hlh-1(cc561ts), which is a hypomorphic allele of hlh-1 viable at 15°C [19] , and dys-1(cx18), which is a putative null allele of dys-1, as its phenotype cannot be distinguished from carboxy-terminal deletions of the gene [15] . At 15°C, hlh-1(cc561ts) worms appeared wild type and showed normal locomotion, except for a small fraction (5-10%), which were born as short, dumpy animals. The dys-1(cx18) worms were slightly hyperactive, but, like hlh-1(cc561ts) worms, left regular wave-like tracks on the plate. The dys-1(cx18); hlh-1(cc561ts) double mutant, in contrast, displayed a progressive impairment of locomotion at adult stages (Table 1, Figures 1,2) . At day 7, approximately 2 days after adulthood began, 100% of the animals had become strongly uncoordinated (Figure 1 ). These animals moved slowly and left irregular tracks on the plate (Figure 2 ). In addition, the double mutant was egg-laying defective, a phenotype not seen in the single mutants (Table 1) . We verified that this phenotype was due to a synergistic effect of the mutations, and not due to a hidden background mutation. The presence of a transgene containing the wild-type genes hlh-1 [19] (Figure 1 ) or dys-1 (data not shown) in the double mutant restored locomotion and egg-laying behaviour to the level observed in the single mutants.
We observed the musculature of the mutants by staining animals with the filamentous actin (F-actin) marker phalloidin, which reveals the sarcomeric organisation of the striated body wall muscles [20] . Most body wall muscles of dys-1(cx18) and hlh-1(cc561ts) animals had a wild-type pattern consisting of a regular arrangement of striated Research Paper Dystrophin-related proteins in C. elegans Gieseler et al. 1093 Table 1 Phenotypes of dys-1; hlh-1 double mutants and animals overexpressing dyc-1.
Genotype
Percentage of Number of Number of uncoordinated animals eggs in utero abnormal muscle cells
Wild type N2 0 ± 0 10.2 ± 1.6 0 ± 0 dys-1(cx18) 0 ± 0 7.5 ± 2.9 0 ± 0 hlh-1(cc561ts) 7 ± 2 14.0 ± 3.5 1.5 ± 1.5 dys-1(cx18); hlh-1(cc561ts) 82 ± 5 24.1 ± 5 13.9 ± 4.5
dys-1(cx18)Ex(dyc-1); hlh-1(cc561ts)
45 ± 4* 8.7 ± 5* 7.2 ± 2.5*
The synergistic effect of the mutations dys-1(cx18) and hlh-1(cc561ts) led to disorganisation of the musculature of the double mutant, resulting in uncoordinated locomotion and egg-laying defects in adults.
In dys-1(cx18)Ex(dyc-1); hlh-1(cc561ts) worms, which overexpress the dyc-1 gene, these phenotypes were partially reversed. The dyc-1 gene encodes a protein related to CAPON. All strains were grown at 15°C. Adults were scored 48 h after the L4 stage, which is approximately day 6 after eggs were laid. Uncoordination is defined as failure to produce three consecutive sinusoidal body waves. Only 40 muscle cells were assessed for each animal (see Materials and methods for details). Data are given as ± SD. *Statistically different from the data for dys-1(cx18); hlh-1(cc561ts), p < 0.01.
Figure 1
The dys-1; hlh-1 double mutants become progressively uncoordinated.
The dys-1(cx18) worms (filled circles) were not uncoordinated; hlh-1(cc561ts) worms (empty circles) were also not uncoordinated except for a small proportion that did not elongate properly and hatched as short, dumpy worms. The dys-1(cx18); hlh-1(cc561ts) double mutants showed normal locomotion as larvae but became uncoordinated as adults (filled squares). This phenotype was reverted in double mutants carrying a wild-type hlh-1 transgene (empty squares).
The horizontal axis shows the number of days after eggs were laid. Adulthood begins at day 5 (strains grown at 15°C). Uncoordination is defined as failure to produce three consecutive sinusoidal body waves. More than 100 animals were scored for each data point. In dys-1(cx18); hlh-1(cc561ts) adults, however, the body wall muscles were severely disorganised, with up to 50% of the cells displaying an abnormal F-actin pattern or no pattern at all (Figure 3d,e) . The alteration of the musculature accounts for the locomotory defects of the dys-1(cx18); hlh-1(cc561ts) animals. The alteration of the muscle F-actin pattern was less frequent in larval stages (Figure 4 ). It correlated with the progressive onset of defective locomotion.
The dys-1(cx18); hlh-1(cc561ts) phenotype is partly suppressed by dyc-1 overexpression
We then searched for genes that could suppress or reduce the phenotype of dys-1(cx18); hlh-1(cc561ts). The gene dyc-1 (for dystrophin-like phenotype and Capon-related) was a good candidate because it belongs to a group of C. elegans genes that we isolated in forward-genetic screens on the basis of their recessive dys-1-like phenotype (L.S., unpublished results). As dys-1 and members of this group share similar phenotypes, and double mutants between members of this group and dys-1 resemble dys-1 animals, it is likely that these genes participate in a common cellular function. Therefore, we tested whether overexpression of dyc-1 could compensate for the absence of dys-1 function, that is, could suppress or reduce the phenotype of dys-1(cx18); hlh-1(cc561ts) animals. Overexpression of dyc-1 partially reduced the locomotion and egg-laying defects of dys-1(cx18); hlh-1(cc561ts) worms (Table 1, Figure 2 ). The proportion of abnormal muscles was also reduced in the animals overexpressing dyc-1 (Table 1 and Figure 3f ). The dyc-1 gene was cloned by positional cloning. It was found to map between the markers unc-9 and unc-3 on the genetic map and to correspond to the predicted gene C33G3.1 (see Materials and methods). The dyc-1 gene encodes a novel protein that has no known homologues in the public sequence databases. We found two regions in the DYC-1 protein with similarity to the rat CAPON protein, which has been identified as a neural nitric oxide synthase (nNOS)-binding protein in a yeast two-hybrid screen [21] (Figure 5 ). DYC-1 is the closest C. elegans relative to CAPON. Within the CAPON-like region of DYC-1, we found a repetition of leucines separated by six amino acids, a motif reminiscent of coiled-coil domains (amino acids 388-412). We assayed dyc-1 expression by reporter gene analysis. For this purpose, we generated DNA constructs consisting of 4 kb of dyc-1 5′ sequences introduced upstream of sequences encoding the green fluorescent protein (GFP) [22] , and injected the constructs into wildtype animals. Transgenic animals expressing DYC-1-GFP showed consistent GFP expression in the head muscles, the body wall muscles, and the vulva muscles ( Figure 6 ). Weaker expression in the intestinal muscles was also -1(cc561ts),  (c) dys-1(cx18), (d) dys-1(cx18) detected in some animals (data not shown). No GFP expression was observed in the pharyngeal muscles nor in non-muscle cells.
Discussion
We have shown that introducing a putative null allele of the C. elegans dys-1 gene in the hlh-1(cc561ts) genetic background results in a progressive and severe alteration of the musculature. Numerous mutations have been isolated in C. elegans that affect muscle structure or function (or both) [23, 24] . Most of these mutations affect larvae as well as adults. It is of particular interest that the phenotype of dys-1(cx18); hlh-1(cc561ts) is time dependent, a trait characteristic of the related disease DMD. This observation is consistent with previous results supporting the hypothesis that the DYS-1 protein and its mammalian counterparts share conserved functions [15] . In mice, the increased severity of the MyoD; mdx mutation, compared with the mdx mutation alone, is thought to be caused by a reduction of the muscle's ability to regenerate from satellite cells, thereby disrupting the equilibrium of degeneration and regeneration that occurs in mdx mice [16] . C. elegans muscles differ from mammalian ones in that they do not contain satellite cells [23] . Therefore, damaged muscle cells are not replaced in C. elegans, leading to the progressive phenotype that we observed. Like its mammalian counterparts of the MyoD family, the hlh-1 gene is required for proper myogenesis. In the absence of the hlh-1 product, which is normally present in mature cells and their precursors, C. elegans body wall muscles form but do not contract properly [18] . The mild hlh-1(cc561ts) mutation has, however, no visible effect on body wall muscles when animals are grown at 15°C [19] . The mechanism underlying the progressive degeneration of the musculature observed in C. elegans dys-1(cx18); hlh-1(cc561ts) mutants is unknown at this point.
Genes involved in a common biological function often produce similar phenotypes when mutated. Based on this idea, we isolated dys-1-like recessive mutations in several genes. One of them (dyb-1) has previously been identified as a homologue of dystrobrevin, a dystrophin-binding protein [25] . We have now reported the cloning of dyc-1, a new member of this class. Recessive mutations of dyc-1 are indistinguishable from dys-1 alleles. The dyc-1 gene has no known homologue, but contains two regions of similarity with the nNOS-binding protein CAPON.
Although nitric oxide has been reported to exist as a neuromediator in Ascaris nematodes [26] , the C. elegans genome does not seem to contain a nNOS homologue (L.S., unpublished results). It is nevertheless intriguing that we have identified a CAPON-related protein in a forward-genetic screen for genes functionally related to dystrophin. In mammals, nNOS is associated with the dystrophin complex, and alterations of this complex lead to a mislocalisation of nNOS [27] . CAPON has been shown to compete with PSD95 for interaction with nNOS [21] , but its in vivo function remains elusive. The fact that a dyc-1 loss-of-function mutant exhibits a dys-1-like phenotype, and that dyc-1 overexpression partially suppresses dys-1(cx18); hlh-1(cc561ts) phenotypes indicate that dys-1 and dyc-1 participate in a common muscular function. In the absence of a strong gain-of-function phenotype of either dys-1 or dyc-1, we cannot perform epistasis tests to place the two genes on a putative pathway. The fact that the dys-1(cx18); hlh-1(cc561ts) phenotype is only partially suppressed by dyc-1 overexpression rules out the possibility that dyc-1 is a unique downstream effector of dys-1 function in C. elegans. Transposed to the mammalian context, our results raise the possibility that CAPON or CAPON-like proteins may antagonise dystrophin-related muscle degeneration, and hence be a possible therapeutic target for DMD treatment.
Conclusions
We have created a C. elegans model of dystrophin-dependent progressive myopathy that will allow systematic screens for gene mutations that revert this phenotype. We have showed that such genes do exist. This model should contribute to the further identification of genes whose modulation may reduce muscle degeneration in humans. Because of its low cost, the C. elegans model can also serve to screen for therapeutic compounds slowing muscle degeneration.
Materials and methods

Observation of phenotypes
Photographs of tracks left by worms on the bacterial lawn were taken by placing regular plates on a Zeiss Stemi dissection microscope at × 50 magnification. For observation of musculature, phalloidin staining was performed as in [20] on adult animals. To synchronise animals, L4 larvae grown at 15°C were picked on new plates, and grown 48 h at 15°C before staining. For quantification of body wall muscle structure, only the centremost 20 cells of the two muscle quadrants facing the objective were observed (40 cells/animals). Data were compared by a paired Student's t-test. Photographs were taken on a Zeiss Axiovert fluorescence microscope using a 40 × objective.
Isolation and characterisation of dyc-1
The dyc-1 alleles cx5 and cx32 were obtained by standard EMS mutagenesis of wild-type N2 animals [28] . The dyc-1 gene was mapped to the X chromosome and subsequently positioned on the genetic map between markers unc-9 and unc-3. Injection of cosmid C33G3 fully rescued dyc-1 alleles. Rescue experiments with portions of C33G3 indicated that dyc-1 corresponds to the predicted gene C33G3.1. The gene structure and amino-acid sequence of dyc-1 was determined by sequencing cDNA clone yk259a5, kindly provided by Y. Kohara, NIG, Japan. The coding sequence was deposited in public databases under accession number AJ133838. The dyc-1(cx5) mutation introduces a stop codon at amino-acid position 378; dyc-1(cx32) is a 2 bp insertion, introducing a frame shift after amino acid 279.
Overexpression of DYC-1-GFP and DYC-1
To determine dyc-1 expression, a dyc-1-gfp transgene was constructed by inserting a 3.9 kb EcoRV-EcoRV fragment (nucleotides 1-3865 of C33G3) into pPD95.75 (A. Fire), and injected into wildtype animals at 50 ng/µl, with pRF4 at 100 ng/ml. For rescue experiments, a 11 kb SalI-Bsu36I fragment (encoding amino acids 1-783 of Dyc-1) was inserted into pPD95.75, and injected at 1 ng/µl, with the transformation marker KP13 [29] at 100 ng/µl, in dyc-1(cx5) worms. For overexpression experiments, the same plasmid was injected at 20 ng/µl, with KP13 at 100 ng/µl, in dys-1(cx18); hlh-1(cc561ts) animals; 3 out of 6 lines obtained showed a consistent reduction of dys-1(cx18); hlh-1(cc561ts) phenotypes and were kept. Overexpression of the protein was confirmed by western blot analysis in the three lines.
Figure 6
The dyc-1 gene is expressed in muscles. (a,b) Dorsal view of the head and anterior part of the body. Staining was restricted to muscle. Head muscles (white arrows) and body wall muscles (white arrowheads) were stained. The pharynx did not express dyc-1 (black arrowheads). 
